Latest chronic liver disease News

Breakthrough Discovery In Fight Against Liver Disease
New Focus For Chronic Liver Disease Care
WHO publishes new guidelines on hepatitis B
Study links deprivation with risk of dying from sepsis
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III trial
More screening vigilance needed to fight chronic liver disease
Too many young people who’ve been in detention die prematurely. They deserve better
Mater Research awards 2023 Strategic Grant for Outstanding Women
Treating liver disease – NHRMC funding boost
Curtin researchers map genetic signature of precursor to liver cancer
Why does severe fatty liver lead to liver damage? Elucidation of the mechanism
Harnessing healing power within our cells
Seven QIMR Berghofer research projects awarded prestigious national grants
Imjudo in combination with Imfinzi approved in US for patients with unresectable liver cancer
Associate Professor Jessica Howell is VCCC Alliance’s inaugural Tony Burgess medallist
Burnet awarded grant to develop next generation liver test
RACGP welcomes winter vaccine campaign
Influenza and Covid vaccination provide important protection this winter
RACGP welcomes winter Covid booster expansion
Tremelimumab accepted under Priority Review in US for patients with unresectable liver cancer
Key protein facilitates regeneration of liver blood vessels
Six reasons to give up drinking
Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive
Development of fatty liver disease under healthy diet
New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial
Daily handful of nuts and seeds can help common chronic liver disease
Stem cell therapy discovery brings lung disease treatment closer
Even mild fatty liver disease is linked to increased mortality
Certain pre-existing conditions may double, triple mortality risk for COVID-19
Budget to deliver better access to life changing medicines for liver cancer, eye conditions and Parkinson’s disease
Stem cell therapies receive MRFF funding
Healthcare efficiency: AI technology to reduce hospital readmissions
Image challenge: unusual calcified lesions of liver and lung in a young woman
How to be medicinewise with ibuprofen in times of COVID-19
Priorities for hep C elimination
UQ extends #1 Nature ranking run
Researchers discover new drug target for liver disease treatment
Chronic liver disease on rise in Queensland
Campaign to reduce liver disease deaths